# CORRESP — KAZIA THERAPEUTICS LTD  (KZIA)  (CIK 0001075880)

> <strong>KAZIA THERAPEUTICS LTD  (KZIA)  (CIK 0001075880) → SEC staff</strong> · filed 2026-03-26 · ticker KZIA · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001213900-26-034709
- **Form:** CORRESP
- **Filer:** KAZIA THERAPEUTICS LTD  (KZIA)  (CIK 0001075880)
- **CIK:** 0001075880
- **Ticker:** KZIA
- **Filed:** 2026-03-26
- **SIC industry:** 2834
- **HQ:** Sydney Nsw

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1075880/000121390026034709/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1075880&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for KAZIA THERAPEUTICS LTD  (KZIA)  (CIK 0001075880)

- UPLOAD — 2026-03-25 — /comment-letter/0000000000-26-003011
- CORRESP — 2025-12-22 — /comment-letter/0001193125-25-328703
- CORRESP — 2025-12-22 — /comment-letter/0001193125-25-328702

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, KAZIA THERAPEUTICS LTD  (KZIA)  (CIK 0001075880) (CIK 0001075880), filed 2026-03-26, accession 0001213900-26-034709. Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/comment-letter/0001213900-26-034709.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*